GSI promotes vincristine-induced apoptosis by enhancing multi-polar spindle formation

Cell Cycle

Volumn 13, Issue 1, 2014, Pages 157-166

  Singh, Akannsha ^a   Zapata, Mariana C ^a   Choi, Yong Sung ^a   Yoon, Sun Ok ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Apoptosis; Centrosome; Gamma secretase inhibitor; Mitotic arrest; Multi polar spindle; Notch; Spindle assembly checkpoint; Vincristine

Indexed keywords

CASPASE; GAMMA SECRETASE INHIBITOR; LIPOCORTIN 5; NOTCH RECEPTOR; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL POPULATION; CELL VIABILITY; CENTROSOME; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; MITOSIS INHIBITION; MITOSIS SPINDLE; SIGNAL TRANSDUCTION;

APOPTOSIS; CENTROSOME; GAMMA SECRETASE INHIBITOR; MITOTIC ARREST; MULTI-POLAR SPINDLE; NOTCH; SPINDLE ASSEMBLY CHECKPOINT; VINCRISTINE;

AMYLOID PRECURSOR PROTEIN SECRETASES; APOPTOSIS; CELL CYCLE; HELA CELLS; HUMANS; MICROTUBULES; OLIGOPEPTIDES; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SPINDLE APPARATUS; VINCRISTINE;

EID: 84892581394     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.26951     Document Type: Article

References (58)

1. Wolfe MS. Intramembrane-cleaving proteases. J Biol Chem 2009; 284: 13969-73; PMID:19189971; http://dx.doi.org/10.1074/jbc.R800039200
2. De Strooper B. Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron 2003; 38: 9-12; PMID:12691659; http://dx.doi.org/10.1016/S0896-6273(03)00205-8 (Pubitemid 36423348)
3. Haapasalo A, Kovacs DM. The many substrates of presenilin/γ- secretase. J Alzheimers Dis 2011; 25:3-28; PMID:21335653
4. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999; 284: 770-6; PMID:10221902; http://dx.doi.org/10.1126/science.284.5415.770 (Pubitemid 29291335)
5. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7:678-89; PMID:16921404; http://dx.doi.org/10.1038/nrm2009 (Pubitemid 44268213)
6. Capaccione KM, Pine SR. The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 2013; 34: 1420-30; PMID:23585460; http://dx.doi.org/10.1093/carcin/bgt127
7. Fan X, Matsui W, Khaki L, Stearns D, Chun J, Li YM, Eberhart CG. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006; 66: 7445-52; PMID:16885340; http://dx.doi.org/10. 1158/0008-5472.CAN-06-0858 (Pubitemid 44289197)
8. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010; 28: 5-16; PMID:19904829
9. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ, Clarke RB. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70: 709-18; PMID:20068161; http://dx.doi.org/10.1158/0008-5472.CAN-09-1681
10. Hovinga KE, Shimizu F, Wang R, Panagiotakos G, Van Der Heijden M, Moayedpardazi H, Correia AS, Soulet D, Major T, Menon J, et al. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 2010; 28: 1019-29; PMID:20506127; http://dx.doi.org/10.1002/stem.429
11. Sikandar SS, Pate KT, Anderson S, Dizon D, Edwards RA, Waterman ML, Lipkin SM. NOTCH signaling is required for formation and self-renewal of tumor-initiating cells and for repression of secretory cell differentiation in colon cancer. Cancer Res 2010; 70: 1469-78; PMID:20145124; http://dx.doi.org/10. 1158/0008-5472.CAN-09-2557
12. Tatarek J, Cullion K, Ashworth T, Gerstein R, Aster JC, Kelliher MA. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. Blood 2011; 118: 1579-90; PMID:21670468; http://dx.doi.org/10. 1182/blood-2010-08-300343
13. Zhu TS, Costello MA, Talsma CE, Flack CG, Crowley JG, Hamm LL, He X, Hervey-Jumper SL, Heth JA, Muraszko KM, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res 2011; 71: 6061-72; PMID:21788346; http://dx.doi.org/10.1158/0008-5472.CAN-10-4269
14. Gürsel DB, Berry N, Boockvar JA. The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network. Neurosurgery 2012; 70:N19-21; PMID:22251985; http://dx.doi.org/10.1227/01. neu.0000410937.38828.6f
15. Hassan KA, Wang L, Korkaya H, Chen G, Maillard I, Beer DG, Kalemkerian GP, Wicha MS. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res 2013; 19: 1972-80; PMID:23444212; http://dx.doi.org/10.1158/1078- 0432.CCR-12-0370
16. Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, Tozzi F, Sceusi E, Zhou Y, Tachibana I, et al. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 2013; 23: 171-85; PMID:23375636; http://dx.doi.org/10.1016/j.ccr.2012.12.021
17. Dong Y, Li A, Wang J, Weber JD, Michel LS. Synthetic lethality through combined Notchepidermal growth factor receptor pathway inhibition in basal-like breast cancer. Cancer Res 2010; 70: 5465-74; PMID:20570903; http://dx.doi.org/ 10.1158/0008-5472.CAN-10-0173
18. Gilbert CA, Daou MC, Moser RP, Ross AH. Gammasecretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence. Cancer Res 2010; 70: 6870-9; PMID:20736377; http://dx.doi.org/10.1158/0008-5472.CAN-10-1378
19. Cook N, Frese KK, Bapiro TE, Jacobetz MA, Gopinathan A, Miller JL, Rao SS, Demuth T, Howat WJ, Jodrell DI, et al. Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma. J Exp Med 2012; 209:437-44; PMID:22351932; http://dx.doi.org/10.1084/jem.20111923
20. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012; 22:373-88; PMID:22975379; http://dx.doi.org/10.1016/j.ccr.2012.07.016
21. McAuliffe SM, Morgan SL, Wyant GA, Tran LT, Muto KW, Chen YS, Chin KT, Partridge JC, Poole BB, Cheng KH, et al. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc Natl Acad Sci U S A 2012; 109:E2939-48; PMID:23019585; http://dx.doi.org/10.1073/pnas. 1206400109
22. Liu YP, Yang CJ, Huang MS, Yeh CT, Wu AT, Lee YC, Lai TC, Lee CH, Hsiao YW, Lu J, et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. Cancer Res 2013; 73: 406-16; PMID:23135908; http://dx.doi.org/10.1158/0008-5472.CAN-12-1733
23. Schott AF, Landis MD, Dontu G, Griffith KA, Layman RM, Krop I, Paskett LA, Wong H, Dobrolecki LE, Lewis MT, et al. Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res 2013; 19: 1512-24; PMID:23340294; http://dx.doi.org/10.1158/1078-0432.CCR- 11-3326
24. Yabuuchi S, Pai SG, Campbell NR, de Wilde RF, De Oliveira E, Korangath P, Streppel MM, Rasheed ZA, Hidalgo M, Maitra A, et al. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett 2013; 335: 41-51; PMID:23402814; http://dx.doi.org/10.1016/j.canlet.2013.01.054
25. Zhang CC, Yan Z, Zong Q, Fang DD, Painter C, Zhang Q, Chen E, Lira ME, John-Baptiste A, Christensen JG. Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models. Stem Cells Transl Med 2013; 2:233-42; PMID:23408105; http://dx.doi.org/10.5966/sctm.2012-0096
26. Akiyoshi T, Nakamura M, Yanai K, Nagai S, Wada J, Koga K, Nakashima H, Sato N, Tanaka M, Katano M. Gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology 2008; 134: 131-44; PMID:18166351; http://dx.doi.org/10.1053/j.gastro.2007.10.008 (Pubitemid 350309314)
27. Tasaka T, Akiyoshi T, Yamaguchi K, Tanaka M, Onishi H, Katano M. Gamma-secretase complexes regulate the responses of human pancreatic ductal adenocarcinoma cells to taxanes. Anticancer Res 2010; 30: 4999-5010; PMID:21187481
28. Janssen A, Medema RH. Mitosis as an anti-cancer target. Oncogene 2011; 30: 2799-809; PMID:21339734; http://dx.doi.org/10.1038/onc.2011.30
29. Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 2007; 8: 379-93; PMID:17426725; http://dx.doi.org/ 10.1038/nrm2163 (Pubitemid 46643240)
30. Jordan MA, Thrower D, Wilson L. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis. J Cell Sci 1992; 102: 401-16; PMID:1506423
31. Andreassen PR, Margolis RL. Microtubule dependency of p34cdc2 inactivation and mitotic exit in mammalian cells. J Cell Biol 1994; 127:789-802; PMID:7962060; http://dx.doi.org/10.1083/jcb.127.3.789
32. Skoufias DA, Andreassen PR, Lacroix FB, Wilson L, Margolis RL. Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc Natl Acad Sci U S A 2001; 98: 4492-7; PMID:11274370; http://dx.doi.org/10.1073/pnas.081076898 (Pubitemid 32295004)
33. Jordan MA, Thrower D, Wilson L. Mechanism of inhibition of cell proliferation by Vinca alkaloids. Cancer Res 1991; 51: 2212-22; PMID:2009540
34. Shin HJ, Baek KH, Jeon AH, Park MT, Lee SJ, Kang CM, Lee HS, Yoo SH, Chung DH, Sung YC, et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 2003; 4: 483-97; PMID:14706340; http://dx.doi.org/10.1016/S1535-6108(03)00302-7
35. Andreassen PR, Skoufias DA, Margolis RL. Analysis of the spindle-assembly checkpoint in HeLa cells. Methods Mol Biol 2004; 281: 213-25; PMID:15220532
36. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis 2000; 21: 485-95; PMID:10688869; http://dx.doi.org/10.1093/carcin/21.3.485 (Pubitemid 30137934)
37. Wu J, Iwata F, Grass JA, Osborne CS, Elnitski L, Fraser P, Ohneda O, Yamamoto M, Bresnick EH. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol Cell Biol 2005; 25: 1458-74; PMID:15684396; http://dx.doi.org/10.1128/MCB.25.4.1458-1474.2005 (Pubitemid 40204922)
38. Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Caskey M, Rizzo P, D'Souza G, Backus K, et al. Crosstalk between PKCα and Notch-4 in endocrineresistant breast cancer cells. Oncogenesis 2013; 2:e60; PMID:23917222; http://dx.doi.org/10.1038/oncsis.2013.26
39. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, et al. Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med 2013; 210:321-37; PMID:23359069; http://dx.doi.org/10.1084/jem.20121527
40. Saunders W. Centrosomal amplification and spindle multipolarity in cancer cells. Semin Cancer Biol 2005; 15: 25-32; PMID:15613285; http://dx.doi.org/10. 1016/j.semcancer.2004.09.003 (Pubitemid 40018525)
41. Doxsey S, Zimmerman W, Mikule K. Centrosome control of the cell cycle. Trends Cell Biol 2005; 15: 303-11; PMID:15953548; http://dx.doi.org/10.1016/j. tcb.2005.04.008 (Pubitemid 40805326)
42. Nigg EA, Raff JW. Centrioles, centrosomes, and cilia in health and disease. Cell 2009; 139:663-78; PMID:19914163; http://dx.doi.org/10.1016/j.cell. 2009.10.036
43. Zyss D, Gergely F. Centrosome function in cancer: guilty or innocent? Trends Cell Biol 2009; 19:334-46; PMID:19570677; http://dx.doi.org/10.1016/j. tcb.2009.04.001
44. Nigg EA. Origins and consequences of centrosome aberrations in human cancers. Int J Cancer 2006; 119: 2717-23; PMID:17016823; http://dx.doi.org/10. 1002/ijc.22245 (Pubitemid 44846221)
45. Fukasawa K. Oncogenes and tumour suppressors take on centrosomes. Nat Rev Cancer 2007; 7:911-24; PMID:18004399; http://dx.doi.org/10.1038/nrc2249 (Pubitemid 350165854)
46. Krämer A, Maier B, Bartek J. Centrosome clustering and chromosomal (in)stability: a matter of life and death. Mol Oncol 2011; 5: 324-35; PMID:21646054; http://dx.doi.org/10.1016/j.molonc.2011.05.003
47. Leber B, Maier B, Fuchs F, Chi J, Riffel P, Anderhub S, Wagner L, Ho AD, Salisbury JL, Boutros M, et al. Proteins required for centrosome clustering in cancer cells. Sci Transl Med 2010; 2:33ra38; PMID:20505215; http://dx.doi.org/ 10.1126/scitranslmed.3000915
48. Lawo S, Bashkurov M, Mullin M, Ferreria MG, Kittler R, Habermann B, Tagliaferro A, Poser I, Hutchins JR, Hegemann B, et al. HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integrity. Curr Biol 2009; 19: 816-26; PMID:19427217; http://dx.doi.org/10.1016/j.cub.2009.04.033
49. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, Pellman D. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 2008; 22:2189-203; PMID:18662975; http://dx.doi.org/10. 1101/gad.1700908
50. Yih LH, Tseng YY, Wu YC, Lee TC. Induction of centrosome amplification during arsenite-induced mitotic arrest in CGL-2 cells. Cancer Res 2006; 66: 2098-106; PMID:16489010; http://dx.doi.org/10.1158/0008-5472.CAN-05-2308
51. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998; 391: 387-90; PMID:9450754; http://dx.doi.org/10.1038/34910 (Pubitemid 28093512)
52. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 1999; 398: 513-7; PMID:10206644; http://dx.doi.org/10.1038/19077
53. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai JY, Rahmati T, Xia W, Selkoe DJ, Wolfe MS. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat Cell Biol 2000; 2: 428-34; PMID:10878808; http://dx.doi.org/10.1038/35017062
54. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, Harrison T, Lellis C, Nadin A, Neduvelil JG, et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 2000; 405: 689-94; PMID:10864326; http://dx.doi.org/10.1038/35015085 (Pubitemid 30428655)
55. Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997; 90: 917-27; PMID:9298903; http://dx.doi.org/10.1016/ S0092-8674(00)80356-6 (Pubitemid 27381630)
56. Nizzari M, Venezia V, Repetto E, Caorsi V, Magrassi R, Gagliani MC, Carlo P, Florio T, Schettini G, Tacchetti C, et al. Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1, 2 signaling. J Biol Chem 2007; 282: 13833-44; PMID:17314098; http://dx.doi.org/10.1074/jbc. M610146200 (Pubitemid 47100564)
57. Judge M, Hornbeck L, Potter H, Padmanabhan J. Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes. Mol Neurodegener 2011; 6:80; PMID:22112898; http://dx.doi.org/10.1186/1750-1326-6-80
58. Boeras DI, Granic A, Padmanabhan J, Crespo NC, Rojiani AM, Potter H. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol Aging 2008; 29: 319-28; PMID:17169464; http://dx.doi.org/10.1016/j. neurobiolaging.2006.10.027 (Pubitemid 351215587)